5-10250426-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012073.5(CCT5):āc.86T>Cā(p.Met29Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00036 in 1,613,692 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M29I) has been classified as Uncertain significance.
Frequency
Consequence
NM_012073.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCT5 | NM_012073.5 | c.86T>C | p.Met29Thr | missense_variant | 1/11 | ENST00000280326.9 | |
CCT5 | NM_001306154.2 | c.86T>C | p.Met29Thr | missense_variant | 1/10 | ||
CCT5 | NM_001306153.1 | c.42+381T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCT5 | ENST00000280326.9 | c.86T>C | p.Met29Thr | missense_variant | 1/11 | 1 | NM_012073.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152200Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000148 AC: 37AN: 250796Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135810
GnomAD4 exome AF: 0.000371 AC: 542AN: 1461374Hom.: 1 Cov.: 37 AF XY: 0.000314 AC XY: 228AN XY: 726978
GnomAD4 genome AF: 0.000256 AC: 39AN: 152318Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 13AN XY: 74486
ClinVar
Submissions by phenotype
Hereditary sensory and autonomic neuropathy with spastic paraplegia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 19, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CCT5 protein function. ClinVar contains an entry for this variant (Variation ID: 350247). This variant has not been reported in the literature in individuals affected with CCT5-related conditions. This variant is present in population databases (rs141133834, gnomAD 0.03%). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 29 of the CCT5 protein (p.Met29Thr). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2022 | CCT5: PM2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at